Hutch News

Hutch News

Stories tagged 'VIDD Research Interests'

Good News at Fred Hutch

Celebrating faculty and staff achievements

June 29, 2017

Dr. Amanda Paulovich of Fred Hutch has been selected to lead a multi-institution effort to develop a biological test to predict which treatments will work for patients with ovarian cancer.

View story >


Stealing a secret from an unwelcome virus

An unexpected discovery in a herpes lab might bring relief to cancer patients

June 29, 2017 | By Sabin Russell / Fred Hutch News Service

Drs. Jia Zhu and Tao Peng made a unexpected discovery while searching for a treatment for herpes: The virus prompts skin cells to make a protein that keeps sensory nerves healthy, and might lead to a treatment for peripheral neuropathy, a side effect of chemotherapy.

View story >


Antimicrobial stewardship preserves a ‘shared resource’

Gains in cancer survival at risk due to surge in multi-drug resistant superbugs

May 4, 2017 | By Mary Engel / Fred Hutch News Service

Antibiotics and other antimicrobials are unique among medications, a “shared resource” that we need to preserve, much as we steward our environment and natural resources, says Fred Hutch clinician-infectious disease researcher Dr. Catherine Liu. Overuse or misuse can lead to drug-resistant bugs that can then spread to new hosts and in some cases even spread their resistance genes to different microorganisms, posing a risk to society at large.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 23, 2017

HIV researcher Julie Overbaugh leads Hutch graduate education; Dr. Janghee Woo named second CTI BioPharma International Postdoctoral Research Fellow

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 5, 2017

Dr. Jonathan Bricker offers 5 steps for keeping resolutions in the new year; Dr. Trevor Bedford a finalist for first-ever Open Science Prize; 425 Magazine salutes HIV researcher Dr. Larry Corey and community advocate Michael Louella

View story >


On the path to a new-generation malaria vaccine

New approach using genetically modified parasite ‘primes the immune system’ in first human trial

Jan. 4, 2017 | By Mary Engel / Fred Hutch News Service

Volunteers in a clinical trial led by Fred Hutch's Dr. Jim Kublin endured 150 to 200 mosquito bites in one 10-minute session to test a new approach to a malaria vaccine that uses genetically attenuated, or weakened, parasites to stimulate an immune response to malaria without causing disease.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.